Synopsis
Synopsis
0
KDMF
0
VMF
0
Australia
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-methoxybenzamide
2. Cerucal
3. Dihydrochloride, Metoclopramide
4. Hydrochloride, Metoclopramide
5. Maxolon
6. Metaclopramide
7. Metoclopramide
8. Metoclopramide Dihydrochloride
9. Metoclopramide Monohydrochloride
10. Metoclopramide Monohydrochloride, Monohydrate
11. Monohydrochloride, Metoclopramide
12. Primperan
13. Reglan
14. Rimetin
1. 7232-21-5
2. Maxolon
3. Metoclopramide Hcl
4. Metoclopramide Monohydrochloride
5. Cerucal
6. Paspertin
7. Clopra
8. Reglan
9. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-methoxybenzamide Hydrochloride
10. Metozolv
11. Metozolv Odt
12. Metoclopramide Hydrochloride Anhydrous
13. 7b1qzy5swz
14. Metoclopramide (hydrochloride)
15. Mls000069667
16. 4-amino-5-chloro-n-[2-(diethylamino)ethyl]-2-methoxybenzamide;hydrochloride
17. Benzamide, 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-methoxy-, Monohydrochloride
18. Nsc-354467
19. Rimetin
20. Smr000058471
21. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-o-anisamide Hydrochloride
22. Primperan (tablet)
23. Metoclopramide Hydrochloride 100 Microg/ml In Acetonitrile
24. Metoclopramide Intensol
25. Reglan Odt
26. Ccris 7142
27. Sr-01000000165
28. Einecs 230-634-5
29. Unii-7b1qzy5swz
30. Nsc 354467
31. 4-amino-5-chloro-n-[2-(diethylamino)ethyl]-o-anisamide Hydrochloride
32. Prestwick_332
33. 4-amino-5-chloro-n-(2-diethylaminoethyl)-2-methoxy-benzamide
34. Mfcd00058011
35. Metoclopramidehcl
36. Opera_id_1671
37. Mls001074186
38. Mls002222202
39. O-anisamide, Monohydrochloride
40. Schembl205200
41. Spectrum1500410
42. Chembl1256771
43. Dtxsid10964306
44. Hms1568j19
45. Hms1920n15
46. Metoclopramide Hydrochloride, Solid
47. Pharmakon1600-01500410
48. Bcp28471
49. Tox21_500762
50. Nsc354467
51. Nsc757117
52. 4-amino-5-chloro-n-(2-diethylaminoethyl)-2-methoxybenzamide Hydrochloride
53. Akos015889947
54. O-anisamide, 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-, Monohydrochloride
55. Ccg-212697
56. Hs-0006
57. Lp00762
58. Nc00519
59. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-methoxybenzamide Monohydrochloride
60. Ncgc00094102-01
61. Ncgc00094102-02
62. Ncgc00094102-03
63. Ncgc00094102-04
64. Ncgc00094102-05
65. Ncgc00261447-01
66. Wln: 2n2&2mvr Dz Cg Fo1 &gh
67. Eu-0100762
68. Ft-0657870
69. Ft-0672375
70. S4289
71. Sw196611-3
72. Vu0239518-5
73. A14247
74. M 0763
75. A923754
76. Sr-01000000165-2
77. Sr-01000000165-7
78. Q27267998
79. 4-amino-5-chloro-n-(2-diethylaminoethyl)-2-methoxybenzamide Hcl
80. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-o-anisamidmonohydrochloride
81. 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-o-anisamide Monohydrochloride
82. Benzamide, 4-amino-5-chloro-n-(2-(diethylamino)ethyl)-2-methoxy-, Monohydrochloride (9ci)
83. Benzamide, 4-amino-5-chloro-n-[2-(diethylamino)ethyl]-2-methoxy-, Hydrochloride (1:1)
Molecular Weight | 336.3 g/mol |
---|---|
Molecular Formula | C14H23Cl2N3O2 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 335.1167324 g/mol |
Monoisotopic Mass | 335.1167324 g/mol |
Topological Polar Surface Area | 67.6 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 300 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Metoclopramide hydrochloride |
Drug Label | Metoclopramide hydrochloride is a white or practically white, crystalline, odorless or practically odorless powder. It is very soluble in water, freely soluble in alcohol, sparingly soluble in chloroform, practically insoluble in ether. Chemically it... |
Active Ingredient | Metoclopramide hydrochloride |
Dosage Form | Tablet; Injectable; Tablet, orally disintegrating; Solution |
Route | Injection; Oral |
Strength | eq 5mg base; eq 5mg base/5ml; eq 5mg base/ml; eq 10mg base |
Market Status | Prescription |
Company | Vintage Pharms; Wockhardt; Silarx; Ani Pharms; Hospira; Teva; Pharm Assoc; Teva Pharms Usa; Northstar Hlthcare; Par Pharm; Novel Labs; Watson Labs; Vistapharm; Ipca Labs; Mutual Pharm; Bd Rx |
2 of 4 | |
---|---|
Drug Name | Metozolv odt |
PubMed Health | Metoclopramide |
Drug Classes | Antiemetic, Diagnostic Agent, Stimulant, Gastrointestinal |
Drug Label | METOZOLV ODT is an orally disintegrating tablet formulation of metoclopramide hydrochloride. The 5 mg strength is a round white tablet debossed on one side with a 5 and plain on the other side; it is comprised of 5 mg metoclopramide (as 5.91... |
Active Ingredient | Metoclopramide hydrochloride |
Dosage Form | Tablet, orally disintegrating |
Route | Oral |
Strength | eq 5mg base |
Market Status | Prescription |
Company | Salix Pharms |
3 of 4 | |
---|---|
Drug Name | Metoclopramide hydrochloride |
Drug Label | Metoclopramide hydrochloride is a white or practically white, crystalline, odorless or practically odorless powder. It is very soluble in water, freely soluble in alcohol, sparingly soluble in chloroform, practically insoluble in ether. Chemically it... |
Active Ingredient | Metoclopramide hydrochloride |
Dosage Form | Tablet; Injectable; Tablet, orally disintegrating; Solution |
Route | Injection; Oral |
Strength | eq 5mg base; eq 5mg base/5ml; eq 5mg base/ml; eq 10mg base |
Market Status | Prescription |
Company | Vintage Pharms; Wockhardt; Silarx; Ani Pharms; Hospira; Teva; Pharm Assoc; Teva Pharms Usa; Northstar Hlthcare; Par Pharm; Novel Labs; Watson Labs; Vistapharm; Ipca Labs; Mutual Pharm; Bd Rx |
4 of 4 | |
---|---|
Drug Name | Metozolv odt |
PubMed Health | Metoclopramide |
Drug Classes | Antiemetic, Diagnostic Agent, Stimulant, Gastrointestinal |
Drug Label | METOZOLV ODT is an orally disintegrating tablet formulation of metoclopramide hydrochloride. The 5 mg strength is a round white tablet debossed on one side with a 5 and plain on the other side; it is comprised of 5 mg metoclopramide (as 5.91... |
Active Ingredient | Metoclopramide hydrochloride |
Dosage Form | Tablet, orally disintegrating |
Route | Oral |
Strength | eq 5mg base |
Market Status | Prescription |
Company | Salix Pharms |
Dopamine D2 Receptor Antagonists
Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS. (See all compounds classified as Dopamine D2 Receptor Antagonists.)
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21271
Submission : 2008-01-22
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-03-02
Pay. Date : 2018-01-12
DMF Number : 4523
Submission : 1982-05-03
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-10
Pay. Date : 2018-08-06
DMF Number : 32991
Submission : 2018-08-03
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-07-28
Pay. Date : 2016-07-21
DMF Number : 4877
Submission : 1983-03-26
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5756
Submission : 1985-03-29
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-01-29
Pay. Date : 2018-07-24
DMF Number : 32884
Submission : 2018-06-19
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-01-11
Pay. Date : 2012-12-10
DMF Number : 7581
Submission : 1988-07-15
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28987
Submission : 2014-12-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5023
Submission : 1983-07-25
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4381
Submission : 1981-09-14
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Metoclopramide Hydrochloride Monohydrate
Certificate Number : CEP 2023-100 - Rev 00
Status : Valid
Issue Date : 2024-03-28
Type : Chemical
Substance Number : 674
Metoclopramide Hydrochloride Monohydrate
Certificate Number : R1-CEP 2015-304 - Rev 00
Status : Valid
Issue Date : 2021-05-20
Type : Chemical
Substance Number : 674
Metoclopramide Hydrochloride Monohydrate
Certificate Number : CEP 2004-075 - Rev 05
Status : Valid
Issue Date : 2024-03-12
Type : Chemical
Substance Number : 674
Metoclopramide Hydrochloride Monohydrate
Certificate Number : CEP 2015-082 - Rev 01
Status : Valid
Issue Date : 2024-03-08
Type : Chemical
Substance Number : 674
METOCLOPRAMIDE DIHYDROCHLORIDE
Registration Number : 221MF10057
Registrant's Address : VIALE DEL GHISALLO, 20 20151 MILAN ITALY
Initial Date of Registration : 2009-03-19
Latest Date of Registration : 2024-12-18
Metoclopramide Hydrochloride BP/USP
Date of Issue : 2022-08-16
Valid Till : 2025-08-15
Written Confirmation Number : WC-0258n
Address of the Firm : Phase III, Gangyal Jammu (J&K)
Metoclopramide Hydrochloride USP
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm : D-24 and D24/1 MIDC Kurkumbh Tal. Daund, Dist Pune 413 802, Maharashtra State
Metoclopramide Hydrochloride (BP/USP/ Ph.Eur)
Date of Issue : 2022-06-08
Valid Till : 2025-07-02
Written Confirmation Number : WC-0091
Address of the Firm : Sejavta, Ratlam, Madhya Pradesh
NDC Package Code : 51604-0005
Start Marketing Date : 2009-10-14
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1549
Start Marketing Date : 2018-01-12
End Marketing Date : 2027-01-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 76003-0739
Start Marketing Date : 2018-01-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 45562-1737
Start Marketing Date : 1998-01-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 40700-0010
Start Marketing Date : 2020-02-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1139
Start Marketing Date : 2012-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57451-1119
Start Marketing Date : 2012-06-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0185
Start Marketing Date : 2012-04-16
End Marketing Date : 2028-07-07
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-1082
Start Marketing Date : 2013-06-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
About the Company : Atman Pharma Private Limited is a fully integrated pharmaceutical company that has distinguished itself as a leader in Bulk Drugs (API) marketing both domestically in India and ove...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
Delivering Quality APIs, Drug Intermediates, and Specialty Chemicals to Over 50 Countries Across the Globe.
About the Company : Zeal MediPharma is a globally recognized Star One Export House, serving customers in over 50 countries for more than two decades. We specialize in sourcing and exporting high-quali...
About the Company : We are a Pharmaceutical Company aligned across two business verticals viz. Products and Services. Our Products business comprises manufacture and sale of APIs and Intermediates to ...
About the Company : Emcure Pharmaceuticals Ltd. is a fast-growing fully integrated Indian pharmaceutical company with a global presence engaged in developing, manufacturing, and marketing a broad rang...
About the Company : ICROM is specialized in the manufacturing and contract manufacturing of Active Pharmaceutical Ingredients (APIs) and GMP intermediates. ICROM is the partner of choice for pharmaceu...
About the Company : Osmopharm S.A. is a GMP approved pharmaceutical company located in Switzerland and specialized in development and production of modified release solid oral form drugs under contrac...
About the Company : Suvan Lifesciences, an organization certified with GMP & ISO standards, stands out as a reputable producer and exporter of high-grade Active Pharmaceutical Ingredients. Our sophist...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
35
PharmaCompass offers a list of Metoclopramide Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Metoclopramide Hydrochloride manufacturer or Metoclopramide Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Metoclopramide Hydrochloride manufacturer or Metoclopramide Hydrochloride supplier.
PharmaCompass also assists you with knowing the Metoclopramide Hydrochloride API Price utilized in the formulation of products. Metoclopramide Hydrochloride API Price is not always fixed or binding as the Metoclopramide Hydrochloride Price is obtained through a variety of data sources. The Metoclopramide Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Metoclopramide HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Metoclopramide HCl, including repackagers and relabelers. The FDA regulates Metoclopramide HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Metoclopramide HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Metoclopramide HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Metoclopramide HCl supplier is an individual or a company that provides Metoclopramide HCl active pharmaceutical ingredient (API) or Metoclopramide HCl finished formulations upon request. The Metoclopramide HCl suppliers may include Metoclopramide HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Metoclopramide HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Metoclopramide HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Metoclopramide HCl active pharmaceutical ingredient (API) in detail. Different forms of Metoclopramide HCl DMFs exist exist since differing nations have different regulations, such as Metoclopramide HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Metoclopramide HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Metoclopramide HCl USDMF includes data on Metoclopramide HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Metoclopramide HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Metoclopramide HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Metoclopramide HCl Drug Master File in Japan (Metoclopramide HCl JDMF) empowers Metoclopramide HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Metoclopramide HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Metoclopramide HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Metoclopramide HCl suppliers with JDMF on PharmaCompass.
A Metoclopramide HCl CEP of the European Pharmacopoeia monograph is often referred to as a Metoclopramide HCl Certificate of Suitability (COS). The purpose of a Metoclopramide HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Metoclopramide HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Metoclopramide HCl to their clients by showing that a Metoclopramide HCl CEP has been issued for it. The manufacturer submits a Metoclopramide HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Metoclopramide HCl CEP holder for the record. Additionally, the data presented in the Metoclopramide HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Metoclopramide HCl DMF.
A Metoclopramide HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Metoclopramide HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Metoclopramide HCl suppliers with CEP (COS) on PharmaCompass.
A Metoclopramide HCl written confirmation (Metoclopramide HCl WC) is an official document issued by a regulatory agency to a Metoclopramide HCl manufacturer, verifying that the manufacturing facility of a Metoclopramide HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Metoclopramide HCl APIs or Metoclopramide HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Metoclopramide HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Metoclopramide HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Metoclopramide HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Metoclopramide HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Metoclopramide HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Metoclopramide HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Metoclopramide HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Metoclopramide HCl suppliers with NDC on PharmaCompass.
Metoclopramide HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Metoclopramide HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Metoclopramide HCl GMP manufacturer or Metoclopramide HCl GMP API supplier for your needs.
A Metoclopramide HCl CoA (Certificate of Analysis) is a formal document that attests to Metoclopramide HCl's compliance with Metoclopramide HCl specifications and serves as a tool for batch-level quality control.
Metoclopramide HCl CoA mostly includes findings from lab analyses of a specific batch. For each Metoclopramide HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Metoclopramide HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Metoclopramide HCl EP), Metoclopramide HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Metoclopramide HCl USP).